Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€857.20

€857.20

1.180%
10.0
1.180%
€828.50

€828.50

 
03.03.26 / Tradegate WKN: 893953 / Symbol: MCK / Name: McKesson / Stock / Food & Drug Retailing / Large Cap /
Latest predictions
€929.22
10.02.26
9.03%
buy
29.01.26
22.98%
buy
22.12.25
23.16%
buy
10.12.25
25.14%
buy
06.11.25
15.62%
buy
€851.52
06.11.25
17.10%
buy
Best running prediction
-
07.08.25
50.18%
buy
Your prediction

McKesson Corp. Stock

McKesson Corp. gained 1.180% today.
The stock is an absolute favorite of our community with 30 Buy predictions and no Sell predictions.
However, we have a potential of -3.41% for McKesson Corp. as the target price of 828 € is below the current price of 857.2 €.

Pros and Cons of McKesson Corp. in the next few years

Pros
?
B****
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of McKesson Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
McKesson Corp. 1.180% 5.463% 19.022% 39.382% 21.485% 163.794% 494.040%
CVS Health Corp. -0.570% 10.002% 6.616% 11.921% 1.688% -9.908% 21.052%
AmerisourceBergen Corp. 0.910% 3.295% 3.714% 31.260% 10.870% 117.813% 269.653%
Cardinal Health Inc. -0.280% 1.563% 5.665% 58.134% 10.613% 175.672% 341.500%

Comments

Prediction Buy
Perf. (%) 9.03%
Target price 929.216
Change
Ends at 10.02.27

McKesson (NYSE:MCK) had its price target raised by analysts at JPMorgan Chase & Co. from $983.00 to $1,107.00. They now have an "overweight" rating on the stock.
Ratings data for MCK provided by MarketBeat
Show more

McKesson (NYSE:MCK) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for MCK provided by MarketBeat
Show more

McKesson (NYSE:MCK) had its "buy" rating reaffirmed by analysts at Cowen Inc.
Ratings data for MCK provided by MarketBeat
Show more